Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03178149
Brief Title: A Phase 1b Dose Escalation Evaluation of Safety and Tolerability and a Phase 2 Proof of Concept Investigation of Efficacy and Safety of ASP7317 for Atrophy Secondary to Age-related Macular Degeneration

First Submitted : May 24, 2017
First Submitted that Met QC Criteria : June 5, 2017
First Posted : June 6, 2017

Last Update Submitted that Met QC Criteria : June 27, 2019
Last Update Posted : June 28, 2019